Hiroaki Toshimitsu

Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit Melanoma

Ryan S. Turley, Andrew N. Fontanella, James C. Padussis et al. · Clinical Cancer Research · 2012 · 57 citations · Full text

Molecular signature linked to acquired resistance to cisplatin in esophageal cancer cells

Hiroaki Toshimitsu, Kiichiro Hashimoto, Akira Tangoku et al. · Cancer Letters · 2004 · 47 citations

Esophageal Cancer, Medicine, Esophageal Cancer Cells +8

Sorafenib, a Multikinase Inhibitor, Enhances the Response of Melanoma to Regional Chemotherapy

Christina K. Augustine, Hiroaki Toshimitsu, Sin‐Ho Jung et al. · Molecular Cancer Therapeutics · 2010 · 45 citations · Full text

Gain of 5p15 detected by comparative genomic hybridization as an independent marker of poor prognosis in patients with esophageal squamous cell carcinoma.

Takashi Ueno, Akira Tangoku, Shigefumi Yoshino et al. · PubMed · 2002 · 38 citations

Esophageal Cancer, Genetics, Comparative Genomic Hybridization +16

Inhibition of Poly(ADP-Ribose) Polymerase Enhances the Effect of Chemotherapy in an Animal Model of Regional Therapy for the Treatment of Advanced Extremity Malignant Melanoma

Hiroaki Toshimitsu, Yasunori Yoshimoto, Christina K. Augustine et al. · Annals of Surgical Oncology · 2010 · 19 citations

Medicine, Melanoma, Animal Model +8